Cargando…
Phenotypic Screening Reveals Topoisomerase I as a Breast Cancer Stem Cell Therapeutic Target
Cancer stem cells (CSCs) are a subpopulation generally thought to be responsible for cancer initiation and progression. Because CSCs are often rare in the total tumor cell population and differentiate rapidly when grown in culture, it has been challenging to uncover compounds that selectively target...
Autores principales: | Zhang, Fang, Rothermund, Kristi, Gangadharan, Sajithlal B., Pommier, Yves, Prochownik, Edward V., Lazo, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660065/ https://www.ncbi.nlm.nih.gov/pubmed/22948175 |
Ejemplares similares
-
In Vivo Evolution of Tumor-Derived Endothelial Cells
por: McGuire, Terence F., et al.
Publicado: (2012) -
The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA–topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts
por: Dexheimer, Thomas S., et al.
Publicado: (2008) -
Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts
por: Graves, J. Anthony, et al.
Publicado: (2010) -
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
por: Pommier, Yves, et al.
Publicado: (2018) -
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study
por: Siu, Fung-Ming, et al.
Publicado: (2013)